OHRP COVID-19 Guidance

The Office for Human Research Protections (OHRP) has provided guidance on COVID-19.  Read More >>

Read More >>

Updated FDA Guidance for COVID19

“FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency,” updated on September 21, 2020.

Read More >>

Notification to Clients: COVID-19 Policy Exception Statement

Salus IRB issues policy exception statement for reviewing study modifications due to COVID-19.

Read More >>